Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $18.58 in the last session, up 6.29% from day before closing price of $17.48. In other words, the price has increased by $6.29 from its previous closing price. On the day, 0.59 million shares were traded. ZLAB stock price reached its highest trading level at $18.99 during the session, while it also had its lowest trading level at $18.38.
Ratios:
We take a closer look at ZLAB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.68 and its Current Ratio is at 2.87. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $55.
BofA Securities Downgraded its Buy to Neutral on March 03, 2025, whereas the target price for the stock was revised from $29 to $36.10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 16 ’25 when Edmondson Frazor Titus III sold 8,651 shares for $17.14 per share. The transaction valued at 148,278 led to the insider holds 19,086 shares of the business.
Edmondson Frazor Titus III bought 8,651 shares of ZLAB for $148,278 on Dec 16 ’25. On Nov 21 ’25, another insider, Edmondson Frazor Titus III, who serves as the Chief Legal Officer of the company, sold 14,328 shares for $19.78 each. As a result, the insider received 283,408 and left with 27,737 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 2054832000 and an Enterprise Value of 20050528256. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.68 while its Price-to-Book (P/B) ratio in mrq is 2.70. Its current Enterprise Value per Revenue stands at 45.401 whereas that against EBITDA is -93.785.
Stock Price History:
The Beta on a monthly basis for ZLAB is 0.82, which has changed by -0.30176628 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $44.34, while it has fallen to a 52-week low of $16.82. The 50-Day Moving Average of the stock is -15.65%, while the 200-Day Moving Average is calculated to be -39.87%.
Shares Statistics:
According to the various share statistics, ZLAB traded on average about 826.03K shares per day over the past 3-months and 1016850 shares per day over the past 10 days. A total of 110.59M shares are outstanding, with a floating share count of 108.86M. Insiders hold about 2.12% of the company’s shares, while institutions hold 28.54% stake in the company. Shares short for ZLAB as of 1765756800 were 5300558 with a Short Ratio of 6.42, compared to 1763078400 on 4603118. Therefore, it implies a Short% of Shares Outstanding of 5300558 and a Short% of Float of 5.43.
Earnings Estimates
The company has 5.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.23 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$1.36 and -$2.05 for the fiscal current year, implying an average EPS of -$1.62. EPS for the following year is -$0.56, with 9.0 analysts recommending between $0.55 and -$1.93.
Revenue Estimates
According to 6 analysts,. The current quarter’s revenue is expected to be $126.26M. It ranges from a high estimate of $128.4M to a low estimate of $122.2M. As of. The current estimate, Zai Lab Limited ADR’s year-ago sales were $109.07MFor the next quarter, 6 analysts are estimating revenue of $130.3M. There is a high estimate of $130.3M for the next quarter, whereas the lowest estimate is $130.3M.
A total of 9 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $489M, while the lowest revenue estimate was $454.76M, resulting in an average revenue estimate of $462.75M. In the same quarter a year ago, actual revenue was $398.99MBased on 15 analysts’ estimates, the company’s revenue will be $681.58M in the next fiscal year. The high estimate is $867M and the low estimate is $508.38M.
